日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Myelin injury precedes axonal injury and symptomatic onset in multiple sclerosis

在多发性硬化症中,髓鞘损伤先于轴突损伤和症状出现。

Abdelhak, Ahmed; Cerono, Gabriel; Sheikhzadeh, Fahime; Harroud, Adil; Ning, Kiarra; Zamecnik, Colin R; Sowa, Gavin M; Boscardin, John; Cordano, Christian; Tubati, Asritha; Fouassier, Camille; Chow, Eric D; Gomez, Refujia; Santaniello, Adam; Zorn, Kelsey C; Hollenbach, Jill A; Oksenberg, Jorge R; Cree, Bruce A C; Hauser, Stephen L; Chan, Jonah R; Baranzini, Sergio E; Wallin, Mitchell T; Wilson, Michael R; Green, Ari J

Five Years of Ublituximab in Multiple Sclerosis: ULTIMATE I and II Open-Label Extension Study

Ublituximab治疗多发性硬化症五年:ULTIMATE I 和 II 开放标签扩展研究

Cree, Bruce A C; Fox, Edward; Hartung, Hans-Peter; Alvarez, Enrique; Qian, Peiqing; Wray, Sibyl; Robertson, Derrick; Selmaj, Krzysztof; Wynn, Daniel; Mok, Koby; Rowland, Chris; Bodhinathan, Karthik; Sportelli, Peter; Miskin, Hari P; Steinman, Lawrence

Development of a Diagnostic Autoantibody Assay to a Consensus Motif for the Risk Prediction of Epstein-Barr Virus-Related Multiple Sclerosis.

针对 Epstein-Barr 病毒相关多发性硬化症风险预测共识基序的诊断性自身抗体检测方法的开发。

McCutcheon Krista M, Bodansky Aaron, Ngo Thomas T, Caspar Colette, Quintana Sydney, Asaki James, Zhou Jing, Caillier Stacy J, Sharathchandra Akshay, Waldrop Greer, Dandekar Ravi, Zorn Kelsey, Tubati Asritha, Gupta Sasha, Sabatino Joseph J, Cuneo Richard, Oksenberg Jorge, Wallin Mitchell T, Cree Bruce A C, Hauser Stephen L, Pleasure Samuel, Derisi Joseph, Wilson Michael R

HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis

HLA-A∗03:01 作为多发性硬化症格拉替雷治疗反应的预测性遗传生物标志物:一项回顾性队列分析

Zhang, Brian C; Schneider-Hohendorf, Tilman; Elyanow, Rebecca; Pignolet, Beatrice; Falk, Simon; Wünsch, Christian; Deffner, Marie; Yusko, Erik; May, Damon; Mattox, Daniel; Dawin, Eva; Gerdes, Lisa Ann; Bucciarelli, Florence; Revie, Lisa; Antony, Gisela; Jarius, Sven; Seidel, Christiane; Senel, Makbule; Bittner, Stefan; Luessi, Felix; Havla, Joachim; Knop, Matthias; Friese, Manuel A; Rothacher, Susanne; Salmen, Anke; Hayashi, Fumie; Henry, Roland; Caillier, Stacy; Santaniello, Adam; Seipelt, Maria; Heesen, Christoph; Nischwitz, Sandra; Bayas, Antonios; Tumani, Hayrettin; Then Bergh, Florian; Meyer Zu Hörste, Gerd; Kümpfel, Tania; Gross, Catharina C; Wildemann, Brigitte; Kerschensteiner, Martin; Gold, Ralf; Meuth, Sven G; Zipp, Frauke; Cree, Bruce A C; Oksenberg, Jorge; Wilson, Michael R; Hauser, Stephen L; Zamvil, Scott S; Klotz, Luisa; Liblau, Roland; Robins, Harlan; Sabatino, Joseph J Jr; Wiendl, Heinz; Schwab, Nicholas

Long-Term Treatment With Ocrelizumab in Patients With Early-Stage Relapsing MS: Nine-Year Data From the OPERA Studies Open-Label Extension

奥瑞珠单抗治疗早期复发型多发性硬化症患者的长期疗效:OPERA 研究开放标签扩展研究的九年数据

Cerqueira, João J; Berthele, Achim; Cree, Bruce A C; Filippi, Massimo; Pardo, Gabriel; Pearson, Owen R; Traboulsee, Anthony; Ziemssen, Tjalf; Vollmer, Timothy; Bernasconi, Corrado; Mandel, Corey R; Kulyk, Inessa; Chognot, Cathy; Raposo, Catarina; Schneble, Hans-Martin; Thanei, Gian-Andrea; Incera, Elodie; Havrdová, Eva K

New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond

多发性硬化症治疗的新视野:2025 年及以后

Sabatino, Joseph J Jr; Cree, Bruce A C; Hauser, Stephen L

The Evolution of Anti-CD20 Treatment for Multiple Sclerosis: Optimization of Antibody Characteristics and Function

多发性硬化症抗CD20治疗的演变:抗体特性和功能的优化

Cree, Bruce A C; Berger, Joseph R; Greenberg, Benjamin

Correction: The Evolution of Anti‑CD20 Treatment for Multiple Sclerosis: Optimization of Antibody Characteristics and Function

更正:抗CD20治疗多发性硬化症的演变:抗体特性和功能的优化

Cree, Bruce A C; Berger, Joseph R; Greenberg, Benjamin

An autoantibody signature predictive for multiple sclerosis

预测多发性硬化症的自身抗体特征

Colin R Zamecnik # ,Gavin M Sowa # ,Ahmed Abdelhak ,Ravi Dandekar ,Rebecca D Bair ,Kristen J Wade ,Christopher M Bartley ,Kerry Kizer ,Danillo G Augusto ,Asritha Tubati ,Refujia Gomez ,Camille Fouassier ,Chloe Gerungan ,Colette M Caspar ,Jessica Alexander ,Anne E Wapniarski ,Rita P Loudermilk ,Erica L Eggers ,Kelsey C Zorn ,Kirtana Ananth ,Nora Jabassini ,Sabrina A Mann ,Nicholas R Ragan ,Adam Santaniello ,Roland G Henry ,Sergio E Baranzini ,Scott S Zamvil ,Joseph J Sabatino Jr ,Riley M Bove ,Chu-Yueh Guo ,Jeffrey M Gelfand ,Richard Cuneo ,H-Christian von Büdingen ,Jorge R Oksenberg ,Bruce A C Cree ,Jill A Hollenbach ,Ari J Green ,Stephen L Hauser ,Mitchell T Wallin ,Joseph L DeRisi ,Michael R Wilson

Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency

自身免疫性维生素B12中枢缺乏症中的转钴胺素受体抗体

John V Pluvinage,Thomas Ngo,Camille Fouassier,Maura McDonagh,Brandon B Holmes,Christopher M Bartley,Sravani Kondapavulur,Charlotte Hurabielle,Aaron Bodansky,Vincent Pai,Sam Hinman,Ava Aslanpour,Bonny D Alvarenga,Kelsey C Zorn,Colin Zamecnik,Adrian McCann,Andoni I Asencor,Trung Huynh,Weston Browne,Asritha Tubati,Michael S Haney,Vanja C Douglas,Martineau Louine,Bruce A C Cree,Stephen L Hauser,William Seeley,Sergio E Baranzini,James A Wells,Serena Spudich,Shelli Farhadian,Prashanth S Ramachandran,Leslie Gillum,Chadwick M Hales,Julie Zikherman,Mark S Anderson,Jinoos Yazdany,Bryan Smith,Avindra Nath,Gina Suh,Eoin P Flanagan,Ari J Green,Ralph Green,Jeffrey M Gelfand,Joseph L DeRisi,Samuel J Pleasure,Michael R Wilson